Get the Stockscreener App
1.53
1.32%
0.02
Pre-market:
1.56
0.03
+1.96%
Predictive Oncology Inc Stock (POAI) Forecast
The Predictive Oncology Inc (POAI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $61.93, representing a +3,948% increase from the current price of $1.53. The highest analyst price target is $95.28, and the lowest is $28.59.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month POAI Price Target
Average 49.39
(+3,128% Upside)
Is Predictive Oncology Inc (POAI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 59.80 | Neutral |
| STOCH(9,6) | 40.12 | Neutral |
| STOCHRSI(14) | 68.39 | Neutral |
| MACD(12,26) | 0.1202 | Sell |
| ADX(14) | 51.47 | Buy |
| William %R | -69.42 | Neutral |
| CCI(14) | 59.73 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.464
Buy
|
1.4591
Buy
|
| MA20 |
1.387
Buy
|
1.3755
Buy
|
| MA50 |
1.0769
Buy
|
1.1687
Buy
|
| MA100 |
0.9042
Buy
|
1.0789
Buy
|
| MA200 |
1.0696
Buy
|
1.3477
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, POAI could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on POAI, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 59.8 indicates that POAI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 40.12 indicates that POAI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 68.39 indicates that POAI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 51.47 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 59.73 indicates that POAI is still overbought but not to an extreme extent.
Long-term POAI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Predictive Oncology Inc financial reports and earnings history, Predictive Oncology Inc (POAI) stock could reach $13.08 by 2030, $7.1624 by 2040 and $15.46 by 2050. See the projected annual prices until 2050 of the Predictive Oncology Inc stock below:
- Predictive Oncology Inc (POAI) is expected to reach an average price of $1.9676 in 2035, with a high prediction of $2.243 and a low estimate of $1.9953. This indicates an $28.60% rise from the last recorded price of $1.53.
- Predictive Oncology Inc (POAI) stock is projected to chart a bullish course in 2040, with an average price target of $8.3924, representing an $448.52% surge from its current level. The forecast ranges from a conservative $6.2647 to a sky-high $7.1624.
- Our analysts predict Predictive Oncology Inc (POAI) to jump 766.03% by 2045, soaring from $12.80 to an average price of $13.25, potentially reaching $12.09. While $12.80 is the low estimate, the potential upside is significant.
- Predictive Oncology Inc (POAI) stock is expected to climb by 2050, reaching an average of $9.5049, a $521.23% jump from its current level. However, a wide range of estimates exists, with high and low targets of $15.46 and $13.30, respectively, highlighting the market's uncertainty.
Predictive Oncology Inc Stock (POAI) Year by Year Forecast
Predictive Oncology Inc Stock (POAI) Price Forecast for 2025
Predictive Oncology Inc Stock (POAI) is expected to reach an average price of $49.77 in 2025, with a high prediction of $95.28 and a low estimate of $4.2653. This indicates an +3,153% rise from the last recorded price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $29.38 | $28.59 | $95.28 | +1,821% |
| April, 2025 | $20.37 | $14.50 | $77.86 | +1,232% |
| May, 2025 | $18.92 | $15.21 | $25.25 | +1,137% |
| June, 2025 | $17.27 | $15.43 | $28.83 | +1,029% |
| July, 2025 | $28.43 | $16.51 | $31.65 | +1,758% |
| August, 2025 | $19.40 | $18.60 | $31.09 | +1,168% |
| September, 2025 | $24.75 | $18.44 | $28.27 | +1,518% |
| October, 2025 | $7.993 | $6.735 | $25.39 | +422.42% |
| November, 2025 | $6.9627 | $6.8068 | $13.64 | +355.08% |
| December, 2025 | $4.5853 | $4.2653 | $8.6063 | +199.69% |
Predictive Oncology Inc Stock (POAI) Price Forecast for 2026
The predicted value for Predictive Oncology Inc (POAI) in 2026 is set at an average of $20.50. Estimates vary from a peak of $37.49 to a trough of $3.5022, indicating an +1,240% surge from the present price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.813 | $3.5022 | $6.413 | +279.93% |
| February, 2026 | $5.2587 | $4.1697 | $8.1017 | +243.70% |
| March, 2026 | $11.31 | $4.1976 | $13.91 | +639.11% |
| April, 2026 | $27.69 | $9.7633 | $37.49 | +1,710% |
| May, 2026 | $20.64 | $10.29 | $28.53 | +1,249% |
| June, 2026 | $21.59 | $12.51 | $23.59 | +1,311% |
| July, 2026 | $9.3449 | $7.7729 | $22.43 | +510.78% |
| August, 2026 | $17.12 | $8.2099 | $24.92 | +1,019% |
| September, 2026 | $16.11 | $11.74 | $20.27 | +952.63% |
| October, 2026 | $13.85 | $13.45 | $17.94 | +805.42% |
| November, 2026 | $14.00 | $11.49 | $14.96 | +815.07% |
| December, 2026 | $19.23 | $11.74 | $20.19 | +1,157% |
Predictive Oncology Inc Stock (POAI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Predictive Oncology Inc (POAI) is $11.30, with a high forecast of $22.18 and a low forecast of $0.4148. This indicates an +638.49% increase from the last price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $17.73 | $12.51 | $22.18 | +1,059% |
| February, 2027 | $14.68 | $13.48 | $19.47 | +859.52% |
| March, 2027 | $12.84 | $10.23 | $15.12 | +739.29% |
| April, 2027 | $11.23 | $11.01 | $14.30 | +634.04% |
| May, 2027 | $10.11 | $8.8867 | $12.44 | +560.69% |
| June, 2027 | $9.9512 | $7.0053 | $10.80 | +550.40% |
| July, 2027 | $13.43 | $9.5821 | $15.86 | +777.97% |
| August, 2027 | $8.2426 | $7.8426 | $13.67 | +438.73% |
| September, 2027 | $1.8252 | $0.4148 | $10.11 | +19.29% |
| October, 2027 | $1.0429 | $1.0429 | $4.3359 | -31.84% |
| November, 2027 | $2.9005 | $2.0318 | $3.8198 | +89.58% |
| December, 2027 | $3.6071 | $2.3313 | $7.1935 | +135.76% |
Predictive Oncology Inc Stock (POAI) Price Forecast for 2028
In 2028, Predictive Oncology Inc (POAI) is projected to reach an average price of $5.0715, with a high projection of $10.06 and a low estimate of $0.0811. This indicates an +231.47% rise from the last price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.7108 | $2.4848 | $3.7421 | +77.18% |
| February, 2028 | $2.2005 | $1.8036 | $3.3636 | +43.83% |
| March, 2028 | $0.6351 | $0.1482 | $2.9954 | -58.49% |
| April, 2028 | $1.8028 | $0.141 | $2.2328 | +17.83% |
| May, 2028 | $2.3215 | $1.9697 | $7.2436 | +51.73% |
| June, 2028 | $4.0731 | $1.4033 | $5.8651 | +166.22% |
| July, 2028 | $4.7688 | $3.322 | $9.3108 | +211.69% |
| August, 2028 | $2.1934 | $2.0174 | $5.5206 | +43.36% |
| September, 2028 | $1.5851 | $1.4182 | $3.2293 | +3.60% |
| October, 2028 | $0.4472 | $0.0811 | $10.06 | -70.77% |
| November, 2028 | $0.0074 | $0.3714 | $0.5697 | -99.52% |
| December, 2028 | $1.4851 | $0.2282 | $2.4151 | -2.94% |
Predictive Oncology Inc Stock (POAI) Price Forecast for 2029
The 2029 price forecast for Predictive Oncology Inc Stock (POAI) is $5.051 on average, with a high prediction of $10.08 and a low estimate of $0.0219. This represents an +230.13% increase from the previous price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6097 | $1.312 | $3.8559 | +70.57% |
| February, 2029 | $1.3274 | $1.1574 | $2.7166 | -13.24% |
| March, 2029 | $0.3151 | $0.1651 | $1.6943 | -79.41% |
| April, 2029 | $1.2128 | $0.0989 | $1.3478 | -20.73% |
| May, 2029 | $0.6374 | $0.1467 | $1.3397 | -58.34% |
| June, 2029 | $0.7851 | $0.3312 | $0.8851 | -48.69% |
| July, 2029 | $1.0227 | $0.5189 | $1.2224 | -33.15% |
| August, 2029 | $0.9874 | $0.4535 | $1.3327 | -35.47% |
| September, 2029 | $1.485 | $0.7472 | $1.825 | -2.94% |
| October, 2029 | $0.9196 | $0.7127 | $1.7719 | -39.89% |
| November, 2029 | $0.4327 | $0.0404 | $1.0966 | -71.72% |
| December, 2029 | $10.66 | $0.0219 | $10.08 | +596.73% |
Predictive Oncology Inc Stock (POAI) Price Forecast for 2030
Predictive Oncology Inc Stock (POAI) is expected to reach an average price of $44.28 in 2030, with a high forecast of $84.56 and a low forecast of $3.9983. This signifies an +2,794% surge from the last price of $1.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $12.05 | $13.45 | $13.08 | +687.63% |
| February, 2030 | $10.74 | $10.96 | $10.18 | +601.66% |
| March, 2030 | $10.66 | $10.66 | $10.06 | +596.73% |
| April, 2030 | $12.34 | $12.31 | $11.36 | +706.84% |
| May, 2030 | $10.50 | $12.74 | $12.16 | +585.98% |
| June, 2030 | $14.02 | $13.37 | $13.37 | +816.21% |
| July, 2030 | $46.74 | $14.82 | $83.52 | +2,955% |
| August, 2030 | $34.37 | $24.82 | $50.73 | +2,147% |
| September, 2030 | $28.46 | $24.06 | $36.00 | +1,760% |
| October, 2030 | $26.43 | $25.53 | $84.56 | +1,627% |
| November, 2030 | $16.33 | $11.52 | $67.32 | +967.09% |
| December, 2030 | $5.8199 | $3.9983 | $22.95 | +280.38% |
10.10%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):